That's a strange argument to take, especially when ppl are dying. Whatever happened to Hippocrates? Consigned to the dumping ground of history no doubt! #EXCELhttps://twitter.com/pomyers/status/1229846385119416322 …
Have they stopped follow up? Why not publish later end points as updates?
-
-
They did (the updated 5yr follow-up in
@NEJM in 2019) - but only after the 2018 guidelines were set in stone and gave a Class I recommendation for stents -
If you buy a mutual fund you get rolling data, from 1 to 3 to 5 to 10 years. Buy/sell recommendations change. Why can't preferred treatment modalities float? Isn't a CABG or an LMS stent an investment? You cannot invest if you cannot evaluate previous investments.
Einde van gesprek
Nieuw gesprek -
Het laden lijkt wat langer te duren.
Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.